Clinical Challenges of Immune Checkpoint Inhibitors

标题

作者

关键词

immunotherapy, PD-1, PD-L1, CTLA-4, hyperprogression, pseudoprogression, treatment-limiting toxicity, optimal immunological dose, time-dependent endpoints, clinical trial design

出版物

CANCER CELL

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2020-08-03

DOI

10.1016/j.ccell.2020.07.004

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now